Looking to publish in Cell Reports Medicine? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowCell Reports Medicine is a premium open-access Cell Press journal publishing translational and clinical biomedical research that informs human health and medicine. It publishes original research across human biology, health, disease, clinical work, translational studies, clinical trials, genomics, biomarker discovery, diagnostic and healthcare technologies, and directly relevant vertebrate model organism studies, along with reports, articles, tools, datasets, and reviews.
Looking to publish in Cell Reports Medicine? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Cell Reports Medicine accepts the following article types. Click on an article type to view submission instructions.
Report
Research Article
Review
Recent Publications
Tryptophan degradation by intestinal Bacteroides induces anti-tumor immunity and limits melanoma growth
Ximena Diaz Olea, Kristin Beede, Gabriel Pereira, David Scott, Christopher Petucci, Eric Martens, Dmitri Rodionov, Aagam Shah, Miguel P. Martinez, Hyungsoo Kim, Ashok Kumar Sharma, Anthony Martin, Tongwu Zhang, Mark B. Faries, Omid Hamid, Suzanne Devkota, Andrei Osterman, Simon Knott, Emile E. Voest, Nadim J. Ajami, Jennifer Wargo, Amanda E. Ramer-Tait, Ze’ev A. Ronai
Targeted antibody-drug conjugates for rhabdomyosarcoma and other FGFR4-expressing cancers
Meijie Tian, Katrina Jia, Jerry T. Wu, Adam T. Cheuk, Siteng Fang, Victor T. Ojo, Eleanor G. Pope, David Milewski, Yong Yean Kim, Hsien-Chao Chou, Avani Kelekar, Soumili Dey, Yunkai Yu, Mohammad Asikur Rahman, R. M. Naseer Khan, Oluwatobi Arisa, William D. Figg, Shyam K. Sharan, Zoe Weaver Ohler, Ludmila Szabova, Simone Difilippantonio, Borys Shor, L. Nathan Tumey, Jun S. Wei, Javed Khan
Repurposed ethoxzolamide reprograms antitumor immunity through β-TrCP-dependent PD-L1 ubiquitination
Xuwen Lin, Qun Wang, Mengting Xu, Dianping Yu, Hongmei Hu, Qing Zhang, Jiannan Yao, Mei Xie, Hanchi Xu, Xuefeng Zang, Jia Li, Yu Chen, Linyang Li, Xiaoyu Tao, Xinru Li, Simeng Li, Shize Xie, Yating Tian, Weidong Zhang, Sanhong Liu, Xinying Xue
Molecular mechanisms and therapeutic perspectives in vulvodynia: From current evidence to future investigations
Alessia Albano, Luna Brasi, Federica Loperfido, Gloria Griffante, Marco Amato Cianci, Giacomo Donati, Valentina Proserpio
Core gastric microbiota linked to pathogenesis and preserved across age-stratified cohorts
Weidong Huang, Qiujin Chen, Xuejie Gao, Gaocheng Yi, Yongyuan Su, Jiayi Shen, Tao Zhang, Hao Zhang, Yanbin Chen, Yingying Yu, Wen Wang, Hewei Jiang, Xu Lin, Zhaowei Xu
Frequently asked questions
How long does it take to publish?
6 days submission to first decision; 43 days submission to decision after review; 205 days submission to acceptance; 27 days acceptance to online publication.
Reformat to Cell Reports Medicine using Livewrite PremiumIs a cover letter required?
A cover letter is included among the materials to prepare for submission.
Reformat to Cell Reports Medicine using Livewrite PremiumWhat are the publication costs?
Elsevier journals publish under subscription and open access models. APCs are set per journal and range between approximately $200 and $11,400 USD excluding tax, with waivers and discounts available in some cases.
Reformat to Cell Reports Medicine using Livewrite Premium